Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route

This study has been completed.
Information provided by (Responsible Party):
University of Oxford Identifier:
First received: December 20, 2011
Last updated: July 1, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):